Author:
Wrensch Margaret,Jenkins Robert B,Chang Jeffrey S,Yeh Ru-Fang,Xiao Yuanyuan,Decker Paul A,Ballman Karla V,Berger Mitchel,Buckner Jan C,Chang Susan,Giannini Caterina,Halder Chandralekha,Kollmeyer Thomas M,Kosel Matthew L,LaChance Daniel H,McCoy Lucie,O'Neill Brian P,Patoka Joe,Pico Alexander R,Prados Michael,Quesenberry Charles,Rice Terri,Rynearson Amanda L,Smirnov Ivan,Tihan Tarik,Wiemels Joe,Yang Ping,Wiencke John K
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. CBTRUS. Primary Brain Tumors in the United States, Statistical Report 2000–2004 (Central Brain Tumor Registry of the United States, Chicago, Illinois, 2008).
2. Schwartzbaum, J.A., Fisher, J.L., Aldape, K.D. & Wrensch, M. Epidemiology and molecular pathology of glioma. Nat. Clin. Pract. Neurol. 2, 494–503 (2006).
3. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
4. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).
5. Bahuau, M. et al. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res. 58, 2298–2303 (1998).